MB
Publications
62
Views
31,176
Downloads
17,607
Supervised works
1
1 - 62 of 62
Title Published in Access level OA Policy Year Views Downloads
Impact des médicaments de la douleur sur le psychisme et la vie émotionnelle : une réflexion pour guider la prescriptionDouleur et analgésie
accessLevelRestricted
2025 3 0
Antipsychotic medication for behaviors that challenge in individuals with intellectual disabilities: a clinically informed reviewFrontiers in psychiatry
accessLevelPublic
2025 31 629
Prise en charge de la douleur aiguë en ambulatoireRevue médicale suisse
accessLevelRestricted
2024 82 0
50 ans de l’IASP : une revue de la vitalité des recherches sur la douleur et des contributions francophonesDouleur et analgésie
accessLevelRestricted
2024 3 0
Alliance thérapeutique et thérapie cognitivo-comportementale de groupeRevue médicale suisse
accessLevelPublic
2023 114 396
De nouvelles perspectives pour Douleur et AnalgésieDouleur et analgésie
accessLevelRestricted
2023 2 0
Thérapie cognitive-comportementale de groupe : quelques éléments cliniques autour des concepts de honte et de culpabilité chez les patients souffrant de douleurs chroniquesDouleur et analgésie
accessLevelRestricted
2023 6 0
Quand la discontinuation des psychotropes s’impose : manifestations cliniques et approche thérapeutiqueRevue médicale suisse
accessLevelPublic
2022 246 272
Hydromorphone Prescription for Pain in Children - What Place in Clinical Practice?Frontiers in pediatrics
accessLevelPublic
2022 187 244
Douleur et troubles du sommeilDouleur et analgésie
accessLevelRestricted
2022 7 0
À propos de l’utilisation du traitement de la kétamine aux urgences psychiatriquesRevue médicale suisse
accessLevelPublic
2021 439 620
Activité, décentration et restructuration cognitive dans la thérapie cognitivocomportementale. Éléments pour la pratique cliniqueRevue médicale suisse
accessLevelPublic
2021 398 1,574
Antibiomania: a case report of clarithromycin and amoxicillin-clavulanic acid induced manic episodes separatelyBMC psychiatry
accessLevelPublic
2021 488 284
CYP450 Genotype-Phenotype Concordance Using the Geneva Micrococktail in a Clinical SettingFrontiers in pharmacology
accessLevelPublic
2021 286 367
Prevalence of Polypharmacy and Inappropriate Medication in Adults With Intellectual Disabilities in a Hospital Setting in SwitzerlandFrontiers in Psychiatry
accessLevelPublic
2021 321 559
Gabapentinoids: The rise of a new misuse epidemics?Psychiatry research
accessLevelPublic
2021 242 518
Cannabinoids and COVID-19Medical Cannabis and Cannabinoids
accessLevelPublic
2020 260 236
Mise au point sur la prise en charge de la douleur chez les patients adultes atteints de déficience intellectuelleDouleur et analgésie
accessLevelRestricted
2020 66 2
GABAergic modulation of secondary hyperalgesia: A randomized controlled 4-way crossover trial with the α2-subunit preferring GABA positive allosteric modulator, N-desmethyl-clobazam in healthy volunteersEuropean Journal of Pain
accessLevelRestricted
2020 265 1
Opioïdes chez les patients âgés: Faux-amis ?La gazette médicale - info@gériatrie
accessLevelRestricted
2020 257 1
Crise suicidaire et prévention du suicide : aspects psychopharmacologiquesRevue médicale suisse
accessLevelPublic
2020 622 698
Antidépresseurs dans la douleur chronique : pourquoi les utiliser, comment les prescrire en pratique ?Revue médicale suisse
accessLevelRestricted
2020 506 3
Pain interventions in adults with intellectual disability: A scoping review and pharmacological considerationsEuropean Journal of Pain
accessLevelRestricted
2020 295 2
TOP-ID: a Delphi technique-guided development of a prescription and deprescription tool for adults with intellectual disabilitiesBMJ Open
accessLevelPublic
2020 383 165
Gestion médicamenteuse des troubles du comportement de la personne en situation de handicap mentalRevue médicale suisse
accessLevelPublic
2020 402 417
Evaluation of Phenotypic and Genotypic Variations of Drug Metabolising Enzymes and Transporters in Chronic Pain Patients Facing Adverse Drug Reactions or Non-Response to Analgesics: A Retrospective StudyJournal of Personalized Medicine
accessLevelPublic
2020 359 131
A case report of cholinergic rebound syndrome following abrupt low-dose clozapine discontinuation in a patient with type I bipolar affective disorderBMC Psychiatry
accessLevelPublic
2019 525 1,709
Psychotropes et perturbation des tests hépatiques : conduite à tenirRevue médicale suisse
accessLevelRestricted
2018 445 2
Phenotypic Assessment of Drug Metabolic Pathways and P-Glycoprotein in Patients Treated With Antidepressants in an Ambulatory SettingJournal of Clinical Psychiatry
accessLevelRestricted
2018 493 0
Exploring venlafaxine pharmacokinetic variability with a phenotyping approach, a multicentric french-swiss study (MARVEL study)BMC Pharmacology & Toxicology
accessLevelPublic
2017 523 223
Screening for genotypic and phenotypic variations in CYP450 activity in patients with therapeutic problems in a psychiatric setting, a retrospective studyPharmacological research
accessLevelPublic
2017 665 195
PIM-Check: development of an international prescription-screening checklist designed by a Delphi method for internal medicine patientsBMJ Open
accessLevelPublic
2017 776 522
Le coût, ce n'est pas tout…à propos des médicaments génériquesRevue médicale suisse
accessLevelRestricted
2016 457 3
The clobazam metabolite N-desmethyl clobazam is an α2 preferring benzodiazepine with an improved therapeutic window for antihyperalgesiaNeuropharmacology
accessLevelPublic
2016 600 342
Topiramate-induced severe heatstroke in an adult patient: a case reportJournal of medical case reports
accessLevelPublic
2016 523 351
Markers of Individual Drug Metabolism: Towards the Development of a Personalized Antidepressant PrescriptionCurrent drug metabolism
accessLevelRestricted
2015 589 3
Prescribing Generic Medication in Chronic Musculoskeletal Pain Patients: An Issue of Representations, Trust, and Experience in a Swiss CohortPloS one
accessLevelPublic
2015 603 318
Providing Quality Therapeutics in Switzerland: Role of the Stakeholders and Recent Incentives for Further ImprovementsClinical therapeutics
accessLevelRestricted
2015 721 6
Douleur et sensibilisation centrale : implication des voies GABAergiques et intérêt de leur modulation
accessLevelRestricted
2015 2,088 19
Baclofen-Associated Onset of Central Sleep Apnea in Alcohol Use Disorder: A Case ReportRespiration
accessLevelRestricted
2015 647 0
Prescription d'antidépresseurs dans le traitement de la douleur : rôle de la pharmacogénétiqueRevue médicale suisse
accessLevelRestricted
2015 572 1
Electrocardiographic Screening for Prolonged QT Interval to Reduce Sudden Cardiac Death in Psychiatric Patients: A Cost-Effectiveness AnalysisPloS one
accessLevelPublic
2015 527 367
GABAergic modulation in central sensitization in humans: a randomized placebo-controlled pharmacokinetic-pharmacodynamic study comparing clobazam with clonazepam in healthy volunteersPain
accessLevelRestricted
2015 629 3
Central Pain Sensitization, COMT Val158Met Polymorphism, and Emotional Factors in FibromyalgiaThe journal of pain
accessLevelRestricted
2014 740 2
Antihyperalgesic Effect of the GABA(A) Ligand Clobazam in a Neuropathic Pain Model in Mice: A Pharmacokinetic-Pharmacodynamic StudyBasic & clinical pharmacology & toxicology
accessLevelPublic
2013 651 462
Reversible ventricular arrythmia induced by dasatinibClinical case reports
accessLevelPublic
2013 659 251
Dual reuptake inhibitor milnacipran and spinal pain pathways in fibromyalgia patients: a randomized, double-blind, placebo-controlled trialPain physician
accessLevelPublic
2013 630 1,155
Evaluation of anti-hyperalgesic and analgesic effects of two benzodiazepines in human experimental pain: a randomized placebo-controlled studyPloS one
accessLevelPublic
2013 664 484
Validation of the simplified UVB model to assess the pharmacodynamics of analgesics in healthy human volunteersChimia
accessLevelPublic
2012 809 1,183
Analgesics in patients with hepatic impairment: pharmacology and clinical implicationsDrugs
accessLevelRestricted
2012 709 3
A randomized, controlled trial validates a peripheral supra-additive antihyperalgesic effect of a paracetamol-ketorolac combinationBasic & clinical pharmacology & toxicology
accessLevelRestricted
2011 682 0
HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic painNeuropharmacology
accessLevelPublic
2011 822 710
Naloxone-responsive acute dystonia and parkinsonism following general anaesthesiaAnaesthesia
accessLevelRestricted
2009 667 0
Two-dimensional liquid chromatography-ion trap mass spectrometry for the simultaneous determination of ketorolac enantiomers and paracetamol in human plasma: application to a pharmacokinetic studyJournal of chromatography
accessLevelRestricted
2009 566 0
Homotopic stimulation can reduce the area of allodynia in patients with neuropathic painEuropean journal of pain
2009 652 0
Influence of ABCB1 gene polymorphisms and P-glycoprotein activity on cyclosporine pharmacokinetics in peripheral blood mononuclear cells in healthy volunteersDrug metabolism letters
2008 864 0
New approaches to the pharmacotherapy of neuropathic painExpert review of clinical pharmacology
2008 590 0
Analgésie et insuffisance rénaleRevue médicale suisse
accessLevelPublic
2008 711 607
La prescription « off-label »Revue médicale suisse
accessLevelRestricted
2008 700 0
Prise en charge médicamenteuse de la douleur neuropathique : quelle place pour les traitements topiques?Revue médicale suisse
accessLevelRestricted
2008 430 0
Automédication chez les sans-papiers latino-américains : entre le nécessaire et l'inappropriéRevue médicale suisse
2007 425 0
Genre et douleur : influence du cycle menstruel sur le seuil expérimental d'apparition de la douleur
accessLevelPublic
2004 1,552 1,567
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack